Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-13.3%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 28.10% |
| Q3 2025 | 1.35% |
| Q2 2025 | -12.56% |
| Q1 2025 | -5.57% |
| Q4 2024 | -8.50% |
| Q3 2024 | -4.22% |
| Q2 2024 | -2.22% |
| Q1 2024 | -2.24% |
| Q4 2023 | -4.09% |
| Q3 2023 | -2.17% |
| Q2 2023 | -0.86% |
| Q1 2023 | 7.29% |
| Q4 2022 | -2.84% |
| Q3 2022 | -4.69% |
| Q2 2022 | -0.03% |
| Q1 2022 | 2.15% |
| Q4 2021 | -2.92% |
| Q3 2021 | -2.89% |
| Q2 2021 | 99.13% |
| Q1 2021 | 53.82% |
| Q4 2020 | 57.30% |
| Q3 2020 | 9.21% |
| Q2 2020 | 1.97% |
| Q1 2020 | -1.28% |
| Q4 2019 | 24.06% |
| Q3 2019 | 15.30% |
| Q2 2019 | 6.90% |
| Q1 2019 | -7.00% |
| Q4 2018 | -9.36% |
| Q3 2018 | -9.03% |
| Q2 2018 | 3.47% |
| Q1 2018 | -8.64% |
| Q4 2017 | 1.82% |
| Q3 2017 | 11.77% |
| Q2 2017 | 5.51% |
| Q1 2017 | 10.45% |
| Q4 2016 | 125.02% |
| Q3 2016 | -3.51% |
| Q2 2016 | -18.75% |
| Q1 2016 | -13.61% |